Keyphrases
Atrial Fibrillation
100%
Thrombogenesis
100%
Matrix Metalloproteinase Inhibitors
100%
Matrix metalloproteinase-1 (MMP-1)
100%
Prothrombotic State
33%
Matrix Degradation
33%
Control Subjects
16%
Enzyme-linked Immunosorbent Assay (ELISA)
16%
Structural Abnormalities
16%
Anticoagulation
16%
Echocardiographic
16%
Consecutive Patients
16%
Plasma Parameters
16%
Sinus Rhythm
16%
Stroke Risk
16%
Thromboembolism
16%
Fibrosis
16%
Prothrombin Fragment 1 + 2
16%
M-mode
16%
Abnormal Index
16%
Structural Remodeling
16%
Atrium
16%
Medicine and Dentistry
Atrial Fibrillation
100%
Blood Clotting
100%
Interstitial Collagenase
100%
Tissue Inhibitor of Metalloproteinase 1
100%
Enzyme Linked Immunosorbent Assay
16%
Apoplexy
16%
Anticoagulation
16%
Sinus Rhythm
16%
Thromboembolism
16%
Fibrosis
16%
Prothrombin
16%
Atrium
16%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Tissue Inhibitor of Metalloproteinase 1
100%
Interstitial Collagenase
100%
Enzyme-Linked Immunosorbent Assay
16%
Cerebrovascular Accident
16%
Thromboembolism
16%
Fibrosis
16%
Prothrombin
16%